Skip to main content

Year: 2026

Prime Drink Group Announces Convertible Debenture, Board Appointment and Grant of Differed Share Units

MONTRÉAL, April 14, 2026 (GLOBE NEWSWIRE) — Prime Drink Group Corp. (CSE: PRME) (“Prime” or the “Company”) announces a non-brokered private placement (the “Private Placement”) of a minimum of 10 units (each, a “Unit”) and a maximum of 16 Units at a price of $250,000 per Unit, for minimum and maximum gross proceeds of $2,500,000 and $4,000,000, respectively. Each Unit will consist of: (i) one $250,000 unsecured convertible debenture (each, a “Debenture”), and (ii) 3,571,429 share purchase warrants (each, a “Warrant”). Each Debenture will have a term of 24 months (the “Term”) and will bear interest at a rate of 7% per annum, payable in cash. At the option of the issuer, the principal amount of each Debenture may be converted, at any time during the Term, into common shares of the Company (each, a “Share”) at a price of $0.055 per...

Continue reading

O2Gold Terminates Quebec Aur Transaction

TORONTO, April 14, 2026 (GLOBE NEWSWIRE) — O2Gold Inc. (NEX:OTGO.H) (“O2Gold” or the “Company”) announces today that it has elected to not extend the term of the share exchange agreement entered into with Quebec Aur Ltd. (“Quebec Aur”) and Quebec Aur’s shareholders dated effective April 15, 2024, as amended, (the “Agreement”) pursuant to which the Company anticipated acquiring a gold mining exploration property in Quebec (the “Acquisition”). As a result the Agreement has been terminated and the Acquisition will not be completed. The Company has also cancelled its previously announced non-brokered private placement financing of 18 million units and 16 million flow-through common shares (the “Offering”) and its previously announced shares for debt settlement agreement, pursuant to which the Company intended to issue 7,000,000 of its...

Continue reading

Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has acquired an exclusive worldwide license to a patented chimeric antigen receptor (CAR) technology platform for precision-enhanced augmentation of therapeutic mesenchymal lineage stromal cell (MSC) products. Mesoblast plans to incorporate the engineered CARs to further boost effectiveness of Mesoblast’s products, with the goal of enhancing the target specificity and augmenting inherent properties of immunomodulation and tissue regeneration. Mesoblast’s MSC technology platforms, including the first and only FDA-approved MSC product in the U.S., are designed for the treatment of tissue-specific inflammatory diseases due to their inherent homing...

Continue reading

GoldHaven Announces Change of Auditor

VANCOUVER, British Columbia, April 14, 2026 (GLOBE NEWSWIRE) — GoldHaven Resources Corp. (“GoldHaven” or the “Company”) (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) announces that pursuant to National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”), on April 10, 2026, Smythe LLP, Chartered Professional Accountants (“Smythe”), was asked to resign by the directors of the Company (the “Board”), as the Company’s auditor, and the Board resolved to appoint Davidson & Company LLP, Chartered Professional Accountants (“Davidson”), as the Company’s successor auditor (the “Change of Auditor”). GoldHaven’s request of Smythe to resign did not occur because of any reportable disagreement or unresolved issue involving the Company, or any consultation with Davidson and was considered, approved and recommended by the Audit Committee...

Continue reading

Northrop Grumman’s B-21 Raider Powers Unmatched Long-Range Strike Capability

Aerial refueling in test unlocks additional speed, flexibility in future operations FALLS CHURCH, Va., April 14, 2026 (GLOBE NEWSWIRE) — Northrop Grumman is accelerating American airpower with the B-21 Raider aircraft, advancing rapidly through its flight test campaign to deliver exceptional warfighting capability. With demonstrated aerial refueling, the B-21 proves it can go anywhere in the world and hold any target at risk to deter and defeat threats.Northrop Grumman’s B-21 Raider continues to demonstrate outstanding performance as the program moves into more advanced phases flight test, including aerial refueling. (Photo Credit: U.S. Air Force) “Our teams are moving the B-21 Raider through testing at an unprecedented pace, continually proving its outstanding performance – including aerial refueling,” said Tom Jones, corporate...

Continue reading

POET Technologies Provides Clarity on its Passive Foreign Investment Company (PFIC) Status

Commits to Taking Actions to Address Potential Tax Consequences to U.S. Shareholders Announces Board Approval to Redomicile in the U.S. TORONTO, April 14, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (Nasdaq: POET) today announced that it will make available the information necessary for its U.S. shareholders to make a “QEF” election. If a U.S. shareholder timely makes such an election, it should mitigate certain potential adverse U.S. federal income tax consequences to it that could otherwise result from the Company’s status as a passive foreign investment company (or “PFIC”) for the year ended December 31, 2025. Further, a U.S. shareholder that makes a QEF election with respect to POET for fiscal year 2025 is not expected to have current income inclusions for fiscal year 2025 as a result of the QEF...

Continue reading

Sompo Expands Capabilities in Australia with New Team and Enhanced Strategic Focus

SYDNEY, Australia, April 14, 2026 (GLOBE NEWSWIRE) — Sompo, a leading global provider of commercial and consumer property and casualty (re)insurance, today announced the expansion of its operations in Australia as it strengthens its presence and long-term commitment to the market.  As part of this strategic growth, Sompo has recruited a highly experienced team of local underwriters who bring established expertise across Property, Casualty, Financial Lines, Energy and Construction. The specialist team of nine, which is known for its solutions-based, client-centric approach, will be based in offices located in Sydney and Melbourne*. Their extensive market knowledge will enhance Sompo’s capabilities, support strong governance and position the business to deliver solutions to clients and brokers throughout the region. It also further...

Continue reading

QuasarEdge Acquisition Corp Prices $100 Million Initial Public Offering

NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) — QuasarEdge Acquisition Corp, a blank check company incorporated in the Cayman Islands as an exempted company (the “Company”), today announced the pricing of its initial public offering (the “IPO”) of 10,000,000 units at an offering price of $10.00 per unit. The units are expected to commence trading on April 15, 2026 on the New York Stock Exchange (“NYSE”) under the ticker symbol “QREDU.” Each unit sold in the offering consists of one ordinary share and one right to receive one-fourth (1/4) of one ordinary share upon the consummation of an initial business combination. Only whole rights will be exchangeable for ordinary shares.  Once the securities comprising the units begin separate trading, the ordinary shares and rights are expected to be listed on NYSE under the symbols “QRED” and...

Continue reading

Imperial Reports Mount Polley Production Update for 2026 First Quarter

VANCOUVER, British Columbia, April 14, 2026 (GLOBE NEWSWIRE) — Imperial Metals Corporation (“Imperial”) (TSX:III) reports production from Mount Polley mine for the 2026 first quarter of 4.399 million pounds copper and 7,608 ounces gold. Copper production was down 51% and gold production was down 28%, on lower grades, recoveries and throughput compared to the first quarter of 2025.Mount Polley Mine Production   Three Months Ended March 31      2026 2025  Ore milled – tonnes   1,499,749 1,721,769  Ore milled per calendar day – tonnes   16,664 19,131  Grade %  – copper   0.186 0.282  Grade g/t  – gold   0.233 0.275  Recovery %  – copper   71.5 83.3  Recovery %  – gold   67.6 69.8  Copper – million pounds   4.399 8.904  Gold – ounces   7,608 10,621  Compared...

Continue reading

Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

MELBOURNE, Australia and INDIANAPOLIS, April 15, 2026 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient has been dosed with TLX101-Tx (¹³¹I-iodofalan) in Telix’s pivotal IPAX BrIGHT trial1, marking the first radiopharmaceutical therapy to enter Phase 3 development for glioblastoma, an aggressive form of brain cancer. The patient was dosed at Austin Health in Melbourne, Australia, under the supervision of Professor Hui Gan. IPAX BrIGHT is assessing the safety and efficacy of TLX101-Tx in combination with chemotherapy (lomustine), compared to chemotherapy alone. The global, multicenter, open-label study will enroll patients with radiographically confirmed recurrent glioblastoma at first recurrence. Telix’s commitment to advancing care for patients with glioblastoma...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.